Cumberland pharmaceuticals reports 16% sequential revenue growth in second quarter 2024

Nashville, tenn. , aug. 6, 2024 /prnewswire/ -- cumberland pharmaceuticals inc. (nasdaq: cpix), a specialty pharmaceutical company, today announced significantly improved financial results and a favorable overall company performance for the second quarter of 2024.

CPIX Ratings Summary

CPIX Quant Ranking